Skip to main content
Premium Trial:

Request an Annual Quote

Beyond Genomics Changes Name to BG Medicine, Pursues Drug-Development Applications

NEW YORK, Feb. 4 (GenomeWeb News) - Shifting its focus, Beyond Genomics has changed its name to BG Medicine and will now pursue the drug-development applications of its systems pharmacology platform, the company said yesterday.


As part of the realignment, the company appointed Pieter Muntendam as its new president, the statement said. Muntendam most recently led the Biopharmaceutical and Healthcare division of NetNumina, an informatics services company, the statement added.


According to BG, its systems pharmacology platform integrates metabolite, protein, and gene transcript profiling to "characterize the molecular changes due to disease or drug effects." The company's goal will be to "improve upon leading drug classes, identify new indications, and explore novel drug combinations," Muntendam said.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.